Therapeutic Drug Monitoring Market: Worldwide Industry Analysis and New Opportunities Explored
Asia Pacific is expected to grow at the highest CAGR during the forecast period
(firmenpresse) - Therapeutic Drug Monitoring Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. The scope of the study includes the various consumables and equipment
What the Market Looks Like?
Predicted to grow at a CAGR of 5.9% during the forecast period, the Global Therapeutic Drug Monitoring Market is estimated to reach USD 1.63 billion by the end of 2023.
Based on product, the global market is segmented into consumables and equipment. The consumables segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the requirement of repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.
Based on technology, the global Therapeutic Drug Monitoring Market is segmented into immunoassays and chromatography-MS. The immunoassays segment is expected to account for the largest share of this market in 2018, mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.
Download PDF Brochure (at) https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443
What Drives the Market?
The growth of the global market for Therapeutic Drug Monitoring is primarily influenced by the following factors:
Geographical growth scenario of Therapeutic Drug Monitoring Market:
Geographically, the TDM Market has been studied for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The APAC market is projected to register the highest growth during the forecast period. Growth in this region can be attributed to the huge demand for better healthcare services; increasing incidence of chronic and infectious diseases; rapid development in healthcare infrastructure in developing countries such as India, China, and South Korea; growing healthcare research investments in this region; and increasing per capita income of the middle-class population.
Get Your Queries Resolved from Subject Expert | Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=155350443
Leading market players and strategies adopted:
The prominent players in the Therapeutic Drug Monitoring Market include F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US). These companies focus on product launches, approvals, and acquisitions to maintain their strong position in the market in the coming years.
F. Hoffmann-La Roche was the leading player in the TDM Market in 2017. The companys the globe. Roche mainly focuses on product launches to maintain its leadership position in the market. For example, in the last three years, the company has launched Elecsys Sirolimus and Everolimus immunosuppressive drug assays for TDM.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales(at)marketsandmarkets.com
Datum: 27.02.2020 - 01:26 Uhr
Sprache: Deutsch
News-ID 1556391
Anzahl Zeichen: 3692
contact information:
Contact person: Sanjay Gupta
Town:
northbook
Phone: 18886006441
Kategorie:
Research & Development
Typ of Press Release: Financial
type of sending: send
Date of sending: 27.02.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 458 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Therapeutic Drug Monitoring Market: Worldwide Industry Analysis and New Opportunities Explored
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
